Cargando…
Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy
Despite aggressive multi-modality treatment with surgery, radiation and chemotherapies, malignant glioma inevitably recurs and has dismal survival rates. Recent progress in immunotherapy has led to a resurgence of interest, and immunotherapies are being investigated for treatment of glioma. However,...
Autores principales: | Kerstetter-Fogle, Amber, Shukla, Sourabh, Wang, Chao, Beiss, Veronique, Harris, Peggy L. R., Sloan, Andrew E., Steinmetz, Nicole F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521079/ https://www.ncbi.nlm.nih.gov/pubmed/30974896 http://dx.doi.org/10.3390/cancers11040515 |
Ejemplares similares
-
Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies
por: Kerstetter-Fogle, Amber E., et al.
Publicado: (2020) -
In situ vaccine application of inactivated CPMV nanoparticles for cancer immunotherapy
por: Chariou, Paul L., et al.
Publicado: (2021) -
Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy
por: Gautam, Aayushma, et al.
Publicado: (2021) -
Glioma stem cells activate platelets by plasma-independent thrombin production to promote glioblastoma tumorigenesis
por: Sloan, Anthony R, et al.
Publicado: (2022) -
Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments
por: Soler, David C., et al.
Publicado: (2021)